Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATShares Issued
Ratios

Cogent Biosciences (COGT) Leases (2019 - 2021)

Cogent Biosciences has reported Leases over the past 3 years, most recently at $3.2 million for Q3 2021.

  • Quarterly results put Leases at $3.2 million for Q3 2021, down 35.61% from a year ago — trailing twelve months through Sep 2021 was $3.2 million (down 35.61% YoY), and the annual figure for FY2020 was $4.6 million, down 12.68%.
  • Leases for Q3 2021 was $3.2 million at Cogent Biosciences, down from $3.7 million in the prior quarter.
  • Over the last five years, Leases for COGT hit a ceiling of $6.3 million in Q1 2019 and a floor of $3.2 million in Q3 2021.
  • Median Leases over the past 3 years was $4.9 million (2020), compared with a mean of $4.9 million.
  • Biggest five-year swings in Leases: fell 10.44% in 2020 and later plummeted 35.61% in 2021.
  • Cogent Biosciences' Leases stood at $5.3 million in 2019, then dropped by 12.68% to $4.6 million in 2020, then decreased by 29.6% to $3.2 million in 2021.
  • The last three reported values for Leases were $3.2 million (Q3 2021), $3.7 million (Q2 2021), and $4.2 million (Q1 2021) per Business Quant data.